Jazz Pharmaceuticals plc (Nasdaq: JAZZ) announced that the U.S. Food and Drug Administration has approved two regimens containing Ziihera (zanidatamab-hrii) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

FDA